NasdaqGS - Nasdaq Real Time Price
USD
Atea Pharmaceuticals, Inc. (AVIR)
4.1000
-0.0100
(-0.24%)
At close: November 2 at 4:00:01 PM EST
4.1000
0.0000
(0.00%)
After hours: November 2 at 4:00:13 PM EST
Trade AVIR on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BERGER FRANKLIN MILAN Director |
Conversion of Exercise of derivative security | Jun 18, 2026 | 536,097 |
| CORCORAN ANDREA J Chief Financial Officer |
Conversion of Exercise of derivative security | Mar 11, 2026 | 823,576 |
| DUNCAN BARBARA GAYLE Director |
Conversion of Exercise of derivative security | Jun 18, 2026 | 92,350 |
| HAMMOND JANET MJ Officer |
Conversion of Exercise of derivative security | Jan 30, 2026 | 127,665 |
| HORGA MARIA ARANTXA Officer |
Conversion of Exercise of derivative security | Jan 30, 2026 | 96,086 |
| LUCIDI BRUNO Director |
Conversion of Exercise of derivative security | Jun 18, 2026 | 142,350 |
| MURPHY POLLY A Director |
Conversion of Exercise of derivative security | Jun 18, 2026 | 121,745 |
| POLSKY BRUCE Director |
Conversion of Exercise of derivative security | Jun 18, 2026 | 124,806 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer |
Conversion of Exercise of derivative security | Feb 3, 2026 | 6,633,860 |
| VAVRICKA JOHN Officer |
Conversion of Exercise of derivative security | Jan 30, 2026 | 165,102 |
